In addition to lung injury, the HMGB1-TLR4-IL-23-IL-17A axis has been reported to contribute to multiple disease models, including the cardiac ischemia-perfusion injury17, brain ischemia-perfusion injury37, drug-induced lethal hepatitis11. This evidence concerns the gene IL17A and myocardial ischemia.